Testing effectiveness (Phase 2)Study completedNCT00073047
What this trial is testing
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
Who this might be right for
Ulcerative ColitisGastrointestinal DiseaseInflammatory Bowel Disease
Facet Biotech 150